The current stock price of SXTC is 1.45 USD. In the past month the price increased by 9.85%. In the past year, price decreased by -43.36%.
Symbol | Company Name | TA | FA | PE | Market Cap |
|---|---|---|---|---|---|
| LLY | ELI LILLY & CO | 48.3 | 1.00T | ||
| JNJ | JOHNSON & JOHNSON | 20.63 | 516.00B | ||
| MRK | MERCK & CO. INC. | 11.38 | 248.85B | ||
| PFE | PFIZER INC | 8.26 | 150.27B | ||
| BMY | BRISTOL-MYERS SQUIBB CO | 8.28 | 110.52B | ||
| ZTS | ZOETIS INC | 19.08 | 53.31B | ||
| RPRX | ROYALTY PHARMA PLC- CL A | 9.37 | 22.24B | ||
| VTRS | VIATRIS INC | 5 | 13.43B | ||
| ELAN | ELANCO ANIMAL HEALTH INC | 22.6 | 10.78B | ||
| CORT | CORCEPT THERAPEUTICS INC | 99.2 | 9.18B | ||
| AXSM | AXSOME THERAPEUTICS INC | N/A | 7.37B | ||
| BLTE | BELITE BIO INC - ADR | N/A | 4.97B |
China Sxt Pharmaceuticals, Inc. operates as a holding company, which engages in the research, development, manufacture, marketing, and sales of traditional Chinese medicine pieces (TCMP). The company is headquartered in Taizhou, Jiangsu and currently employs 75 full-time employees. The company went IPO on 2019-01-04. TCMP is a type of Chinese Traditional Medicine (TCM) products. The firm sells three types of TCMP products: Advanced TCMP, Fine TCMP and Regular TCMP. The firm sells its products under the brand Suxuantang. The firm mainly operates its businesses in the domestic market.
CHINA SXT PHARMACEUTICALS IN
178 Taidong Road North
Taizhou JIANGSU 225300 CN
CEO: Feng Zhou
Employees: 75
Phone: 8652386298290
China Sxt Pharmaceuticals, Inc. operates as a holding company, which engages in the research, development, manufacture, marketing, and sales of traditional Chinese medicine pieces (TCMP). The company is headquartered in Taizhou, Jiangsu and currently employs 75 full-time employees. The company went IPO on 2019-01-04. TCMP is a type of Chinese Traditional Medicine (TCM) products. The firm sells three types of TCMP products: Advanced TCMP, Fine TCMP and Regular TCMP. The firm sells its products under the brand Suxuantang. The firm mainly operates its businesses in the domestic market.
The current stock price of SXTC is 1.45 USD. The price increased by 2.84% in the last trading session.
SXTC does not pay a dividend.
SXTC has a ChartMill Technical rating of 2 out of 10 and a ChartMill Fundamental rating of 2 out of 10.
SXTC stock is listed on the Nasdaq exchange.
You can find the ownership structure of CHINA SXT PHARMACEUTICALS IN (SXTC) on the Ownership tab.
ChartMill assigns a technical rating of 2 / 10 to SXTC. When comparing the yearly performance of all stocks, SXTC is a bad performer in the overall market: 91.14% of all stocks are doing better.
ChartMill assigns a fundamental rating of 2 / 10 to SXTC. The financial health of SXTC is average, but there are quite some concerns on its profitability.
Over the last trailing twelve months SXTC reported a non-GAAP Earnings per Share(EPS) of -3.01. The EPS increased by 97.31% compared to the year before.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PM (TTM) | N/A | ||
| ROA | -15.25% | ||
| ROE | -21.4% | ||
| Debt/Equity | 0.05 |